In soft tissue sarcomas and gastrointestinal stromal tumors, Akt signaling inhibition decreased the RAD51 protein level by regulating protein stability, decreasing the efficacy of homology-mediated repair of DNA DSBs, and ultimately sensitizing tumor cells to doxorubicin (43). The gene discussed is AKT1; the disease is gastrointestinal stromal tumor.